Chrysalis Pharma Private Limited
About Chrysalis Pharma Private Limited
Data last updated:
Chrysalis Pharma Private Limited is a private limited company based in Pinjore, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR2014PTC052499. Its GSTIN is 02AAFCC6811R1ZH (Himachal Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Shahi and Riyaz Uddin Khan.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Khasra No. – 205 Shiv Colony Near Lic Office Bitna Road, Pinjore, Haryana, India – 134102.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.57 Lakh, a decline of 79% compared to the previous year. For the same year it recorded a net loss of ₹3,082 (net margin -0.5%) and EBITDA of -₹3,082 (EBITDA margin -0.5%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Chrysalis Pharma Private Limited's registered office is in Pinjore, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhasra No. – 205 Shiv Colony Near Lic Office Bitna Road, Pinjore, Haryana, India – 134102
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Chrysalis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chrysalis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Chrysalis Pharma Private Limited, buy the company report.
Financials of Chrysalis Pharma Private Limited
FY 2022 filings availableChrysalis Pharma Private Limited reported revenue of ₹6.57 Lakh (down 79% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 35% over three years, including a 79% fall in the latest year. EBITDA fell 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3,082 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,082 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chrysalis Pharma Private Limited, buy the company report.
Board of directors of Chrysalis Pharma Private Limited
Chrysalis Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Shahi | Director | 11 Jun 2014 | 12 Years 5 Months | Current |
| Riyaz Uddin Khan Also directs: Biomade Life Sciences LLP, Biomade Life Care Private Limited | Director | 11 Jun 2014 | 12 Years 5 Months | Current |
Peer comparison
Chrysalis Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srushti Medicines Private Limited | ₹6.57 Lakh (FY 2018) | 41.0% | Raipur, Chhattisgarh, India | |||
| Chrysalis Pharma Private Limitedthis company | ₹6.57 Lakh (FY 2022) | -₹3,082 | -0.5% | -79.0% | Pinjore, Haryana, India | |
| Leventis Laboratories Private Limited | ₹6.51 Lakh (FY 2024) | 54.0% | Fazalpur, Delhi, India | |||
| Sapp Life Sciences Private Limited | ₹6.5 Lakh (FY 2023) | 13.0% | New Delhi, Delhi, India | |||
| Adreama Biotech Private Limited | ₹6.5 Lakh (FY 2024) | 22.0% | New Delhi, Delhi, India | |||
| Alenrise Retail Private Limited | ₹6.5 Lakh (FY 2024) | -80.0% | Yamuna Nagar, Haryana, India |
To see the full peer comparison of Chrysalis Pharma Private Limited, buy the company report.
Auditor
Chrysalis Pharma Private Limited is audited by A PASARI & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A PASARI & ASSOCIATES | FY 2020 | 022611N |
Shareholding
The shareholding of Chrysalis Pharma Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chrysalis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Chrysalis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chrysalis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Chrysalis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAFCC6811R1ZH | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Chrysalis Pharma Private Limited, buy the company report.
Recent activity
Chrysalis Pharma Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Shankar Kumar Singh ceased to be Director on 10 Jun 2019.
Frequently asked questions
Chrysalis Pharma is an active private limited company based in Pinjore, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 June 2014 (12+ years old) and is registered under CIN U24239HR2014PTC052499.
Chrysalis Pharma has 2 current directors:
- Anil Kumar Shahi - Director
- Riyaz Uddin Khan - Director
The latest financial statements of Chrysalis Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Chrysalis Pharma is 02AAFCC6811R1ZH, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Chrysalis Pharma is U24239HR2014PTC052499. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chrysalis Pharma was incorporated on 11 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Chrysalis Pharma by revenue are Srushti Medicines Private Limited, Leventis Laboratories Private Limited, Sapp Life Sciences Private Limited, Adreama Biotech Private Limited, Alenrise Retail Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Shankar Kumar Singh ceased to be Director on 10 Jun 2019. Mahesh Pandit ceased to be Director on 15 Dec 2014. Anil Kumar Shahi was appointed as Director on 11 Jun 2014. Chrysalis Pharma has 4 board changes on record in total.
The registered office of Chrysalis Pharma is at Khasra No. – 205 Shiv Colony Near Lic Office Bitna Road, Pinjore, Haryana, India – 134102.
Chrysalis Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Chrysalis Pharma is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
